Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration. 1988

T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
Department of Anaesthesia, Bispebjerg Hospital, Copenhagen, Denmark.

1. In an open cross-over trial, plasma concentrations of midazolam were measured in eight healthy male volunteers following administration of 0.3 mg kg-1 body weight given by the rectal and intravenous routes. 2. Maximum plasma concentrations of 92-156 ng ml-1 (mean 118 ng ml-1) were recorded from 20 to 50 min (mean 31 min) after rectal application. The rectal bioavailability was 40-65% (mean 52%) and the terminal half-life was 114-305 min (mean 161 min). 3. A substantial first-pass hepatic effect was observed following rectal administration. 4. No systemic or local intolerance was noted. 5. In conclusion, the rectal route of administration provides a rapid and reliable absorption of midazolam.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000285 Administration, Rectal The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. Anal Drug Administration,Drug Administration, Rectal,Instillation, Rectal,Rectal Drug Administration,Drug Administration, Anal,Rectal Administration,Administration, Anal Drug,Administration, Rectal Drug,Administrations, Anal Drug,Administrations, Rectal,Administrations, Rectal Drug,Anal Drug Administrations,Drug Administrations, Anal,Drug Administrations, Rectal,Instillations, Rectal,Rectal Administrations,Rectal Drug Administrations,Rectal Instillation,Rectal Instillations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
September 1998, British journal of clinical pharmacology,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
December 1989, Der Anaesthesist,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
October 2013, Journal of veterinary pharmacology and therapeutics,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
May 2017, American journal of veterinary research,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
November 2013, Equine veterinary journal,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
June 1989, Der Anaesthesist,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
January 1986, British journal of clinical pharmacology,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
June 2009, New Zealand veterinary journal,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
May 1978, The Journal of antimicrobial chemotherapy,
T G Clausen, and J Wolff, and P B Hansen, and F Larsen, and S N Rasmussen, and J S Dixon, and C Crevoisier
February 2013, American journal of veterinary research,
Copied contents to your clipboard!